Shilhav Meisel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Shilhav Meisel has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Anastasia Firsow
Department of Clinical Microbiology and Immunology, Sackler Faculty School of Medicine, Tel Aviv University, Ramat-Aviv, Tel Aviv 69978, Israel
1 shared publication - Gili Perry
Department of Clinical Microbiology and Immunology, Sackler Faculty School of Medicine, Tel Aviv University, Ramat-Aviv, Tel Aviv 69978, Israel
1 shared publication - Maayan Amit
Department of Clinical Microbiology and Immunology, Sackler Faculty School of Medicine, Tel Aviv University, Ramat-Aviv, Tel Aviv 69978, Israel
1 shared publication - Michal Caspi
Tel Aviv University
1 shared publication - Nir Skalka
Departments of Molecular Biology and Nutrition Sciences, Ariel University, Ariel 40700, Israel
1 shared publication - Rina Rosin-Arbesfeld
Department of Clinical Microbiology and Immunology, Sackler School of Medicine, Tel Aviv University, Ramat-Aviv, 69978, Tel Aviv, Israel.
1 shared publication
Latest Publications
- Open Access
- 4 July 2014
- Published by Springer Nature in Molecular Cancer
- Vol. 13 (1) , 164
Aldolase positively regulates of the canonical Wnt signaling pathway
The Wnt signaling pathway is an evolutionary conserved system, having pivotal roles during animal development. When over-activated, this signaling pathway is involved in cancer initiation and progression. The canonical Wnt pathway regulates the stability of β-catenin primarily by a destruction complex containing a number of different proteins, including Glycogen synthase kinase 3β (GSK-3β) and Axin, that promote proteasomal degradation of β-catenin. As this signaling cascade is modified by various proteins, novel screens aimed at identifying new Wnt signaling regulators were conducted in our laboratory. One of the different genes that were identified as Wnt signaling activators was Aldolase C (ALDOC). Here we report that ALDOC, Aldolase A (ALDOA) and Aldolase B (ALDOB) activate Wnt signaling in a GSK-3β-dependent mechanism, by disrupting the GSK-3β-Axin interaction and targeting Axin to the dishevelled (Dvl)-induced signalosomes that positively regulate the Wnt pathway thus placing the Aldolase proteins as novel Wnt signaling regulators.
- 4 July 2014
- Published by Springer Nature in Molecular Cancer
- Vol. 13 (1) , 164
Open AccessAldolase positively regulates of the canonical Wnt signaling pathway
The Wnt signaling pathway is an evolutionary conserved system, having pivotal roles during animal development. When over-activated, this signaling pathway is involved in cancer initiation and progression. The canonical Wnt pathway regulates the stability of β-catenin primarily by a destruction complex containing a number of different proteins, including Glycogen synthase kinase 3β (GSK-3β) and Axin, that promote proteasomal degradation of β-catenin. As this signaling cascade is modified by various proteins, novel screens aimed at identifying new Wnt signaling regulators were conducted in our laboratory. One of the different genes that were identified as Wnt signaling activators was Aldolase C (ALDOC). Here we report that ALDOC, Aldolase A (ALDOA) and Aldolase B (ALDOB) activate Wnt signaling in a GSK-3β-dependent mechanism, by disrupting the GSK-3β-Axin interaction and targeting Axin to the dishevelled (Dvl)-induced signalosomes that positively regulate the Wnt pathway thus placing the Aldolase proteins as novel Wnt signaling regulators.